Study indicates that fathers who exercise before conception produce children who are healthier throughout their lives – Joslin Diabetes Center – Recent studies. Guías ALAD sobre el diagnóstico, control y tratamiento de la Diabetes Mellitus Tipo 2 con medicina basada en evidencia. Edición Global estimates of diabetes prevalence for and projections for .. Guías ALAD de diagnóstico, control y tratamiento de la diabetes mellitus tipo 2.

Author: Tagore Moogucage
Country: Cayman Islands
Language: English (Spanish)
Genre: History
Published (Last): 20 September 2008
Pages: 455
PDF File Size: 20.95 Mb
ePub File Size: 18.57 Mb
ISBN: 789-7-15345-350-8
Downloads: 70392
Price: Free* [*Free Regsitration Required]
Uploader: Samubar

Asociación Latinoamericana de Diabetes – ALAD

N Engl J Med ; IDF Global diaebtes for managing older people with type 2 diabetes. Kidney Int ; SGLT-2 inhibitors and cardiovascular risk: A week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes.

Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with diabees or sitagliptin compared to metformin or glyburide. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes.

Food and Drug Administration, Questions and answers: Adv Ther ; Effects of exercise on glucose homeostasis in type 2 diabetes mellitus. Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.


Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control.

Acarbose is an alpha glycosidase inhibitor that is less effective in reducing hyperglycaemia than other oral antidiabetic agents.

Beneficial effect on average lipid levels from energy restriction and fat loss in obese individuals with or without type 2 diabetes. Combination therapy has been shown to be more effective than monotherapy, with lower risk of side-effects. Curr Opin Nephrol Hypertens alax Effects of SGLT2 inhibitors on cardiovascular outcomes.

Current global guidelines for type 2 diabetes treatment

Med Sci Sports Exerc. Management of hyperglycemia in type 2 diabetes, Secondary prevention of macrovascular events in patients with type 2 diabetes: Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. Metformin prevents weight gain by reducing dietary intake during insulin therapy in patients with mellifus 2 diabetes mellitus.

High-monounsaturated-fat diets for patients with diabetes mellitus: Current global guidelines for type 2 diabetes treatment. Normalization of insulin sensitivity in the obese patient after stable weight reduction with biliopancreatic diversion.


Physical activity and prevention of diabeges 2 diabetes mellitus. A patient-centered approach should be used to guide choice of pharmacological agents.

Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.

Revista de la Sociedad Argentina de Diabetes http: J Hum Hypertens ; June 13, DOI: Diabetes Care ; De Fronzo R, et al.

Options for combination therapy in type 2 diabetes: Br J Diabetes Vasc Dis. Richter B, Bandeira-Echtler E, et al.

Clinical experience with this agent is limited. Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: 203 Research and Clinical Practice ; 2: Long-acting insulin analogues versus NPH insulin human isophane insulin for type 2 diabetes mellitus.

Sodium-glucose cotransporter-2 inhibition and the potential for renal protection in diabetic nephropathy.